The Foundation delivers, on average, 120 million annual doses to the National Immunization Program, a number that increased during the pandemic. Fiocruz’s immunizers portfolio comprises 12 products, including vaccines against COVID-19, yellow fever, polio, and MMR (measles, mumps and rubella)